Journal of Yeungnam Medical Science

Seung Woo Lee

1 Article

Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression: Hye-Geum Kim, Bon-Hoon Koo, Seung Woo Lee, Eun-Jin Cheon; Yeungnam Univ J Med. 2019;36(3):249-253. Published online March 15, 2019; DOI: https://doi.org/10.12701/yujm.2019.00150

15,171 View
171 Download
3 Crossref

There is considerable overlap in the clinical presentations of apathy and depression. However, differential diagnosis between apathy and other psychiatric conditions, including depression and dementia, is important. In this report, we present the case of a 67-year-old woman with a history of receiving selective serotonin reuptake inhibitor (SSRI) treatment for depression. Differential diagnosis between treatment-resistant depression and SSRI-induced apathy syndrome was required. The symptoms of her apathy syndrome were relieved after the discontinuation of SSRIs and the addition of olanzapine, methylphenidate, and modafinil. Furthermore, we briefly review related literature in this article.

Citations

Citations to this article as recorded by

Apathy associated with antidepressant drugs: a systematic review
Vasilios G. Masdrakis, Manolis Markianos, David S. Baldwin
Acta Neuropsychiatrica.2023; 35(4): 189. CrossRef
Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literature
Muhammad Youshay Jawad, Maurish Fatima, Umer Hassan, Zaofashan Zaheer, Muhammad Ayyan, Muhammad Ehsan, Muhmmad Huzaifa Ahmed Khan, Ahsan Qadeer, Abdul Rehman Gull, Muhammad Talha Asif, Mujeeb U. Shad
Human Psychopharmacology: Clinical and Experimental.2023;[Epub] CrossRef
Investigation of the efficiency of various antidepressant replacement regimens in the development of SSRI-induced apathy syndrome
V. E. Medvedev, R. A. Kardashyan, V. I. Frolova, A. M. Burno, S. V. Nekrasova, V. I. Salyntsev
Neurology, Neuropsychiatry, Psychosomatics.2020; 12(2): 48. CrossRef

Author index